Back to Journals » Research and Reports in Urology » Volume 11

Prostate cancer “super-active surveillance” era opened by vascular targeted photodynamic therapy

Authors Corradi RB, Travassos TC, Reis LO

Received 26 December 2018

Accepted for publication 26 April 2019

Published 29 May 2019 Volume 2019:11 Pages 157—163


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Dr Jan Colli

Renato B Corradi,1,2 Thiago C Travassos,1,2 Leonardo O Reis1,2

1UroScience, Pontifical Catholic University of Campinas, Campinas, SP, Brazil; 2University of Campinas, Campinas, SP, Brazil

Abstract: The “super-active surveillance” concept denotes any active surveillance optimization that allows longer surveillance periods, with the main intention of avoiding overtreatment, by safely eliminating or postponing radical treatment. Super-active surveillance might add to the oncological control with minimal functional impact and similar quality of life compared to active surveillance, which has proved to be safe in well-selected patients. Vascular targeted photodynamic therapy has pioneering shown to significantly reduce the upgrade on subsequent biopsies, resulting in fewer cases converted to radical therapy, and any energy source can be applied to the super-active surveillance concept allowing more men to consider a tissue-preserving therapy for prostate cancer.

Keywords: Super-active surveillance, ablation, minimally invasive

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]